NCT02640677View on ClinicalTrials.gov

Safety of 4CMenB Exposure During Pregnancy

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL

4CMenB

This study is strictly observational; Administration of BEXSERO, the schedule of office visits and all treatment regimens will be determined by the treating health care provider in the context of routine clinical care.

Trial Locations (1)

28401-3331

GSK Investigational Site, Wilmington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02640677 - Safety of 4CMenB Exposure During Pregnancy | Biotech Hunter | Biotech Hunter